Importantly, we demonstrated that the tumors with a greater percentage of high-TAB182-expressing cells, which are also exhibiting highly expressed ALDH1A1, are linked to a poor prognosis among ESCC patients. Here, ALDH1A1 is linked to esophageal squamous cell carcinoma.